BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 7091574)

  • 1. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
    Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.
    Overturf GD; Rigau-Perez JG; Selzer J; Field RJ; Powars D; Pang EJ; Uy C; Honig G; Weiss J; Chan L; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):19-23. PubMed ID: 7091573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
    Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
    N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections.
    Hidalgo H; Moore C; Leiva LE; Sorensen RU
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal polysaccharide immunization in infants and children.
    Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
    Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses against pneumococcal polysaccharide antigens in vaccinated persons.
    Leinonen M
    Ann Clin Res; 1982 Dec; 14(5-6):267-71. PubMed ID: 7171234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
    Kaplan J; Sarnaik S; Schiffman G
    Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
    Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
    J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in sickle cell anemia: pathogenesis and control.
    Overturf G; Powars D
    Tex Rep Biol Med; 1980-1981; 40():283-92. PubMed ID: 7034272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
    Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.
    Baker CJ; Kasper DL; Edwards MS; Schiffman G
    N Engl J Med; 1980 Jul; 303(4):173-8. PubMed ID: 6155612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection prevention following splenectomy: protective effect of a new 17-valent pneumococcal vaccine].
    Tillmann W; Burow M; Schröter W
    Monatsschr Kinderheilkd; 1983 Dec; 131(12):848-52. PubMed ID: 6664357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
    Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pneumococcal conjugate vaccine.
    Jacobson RM; Poland GA
    Minerva Pediatr; 2002 Aug; 54(4):295-303. PubMed ID: 12131865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression.
    Laferriere C
    Vaccine; 2011 Sep; 29(40):6838-47. PubMed ID: 21816198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal infection and immunization in children.
    Lee CJ; Wang TR
    Crit Rev Microbiol; 1994; 20(1):1-12. PubMed ID: 8185832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-immunization pneumococcal antibody titers and IgG subclasses.
    Sorensen RU; Hidalgo H; Moore C; Leiva LE
    Pediatr Pulmonol; 1996 Sep; 22(3):167-73. PubMed ID: 8893255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and reactogenicity of new multivalent pneumococcal vaccines.
    Wiedermann G; Jovanovic D; Georges AM; Hauser P; Ambrosch F
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Apr; 251(4):494-504. PubMed ID: 7201725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiology of invasive pneumococcal disease in Queensland, 1990 to 1997.
    Gratten M; Carlisle J; Hanna J; Bapty G; George N; Nuttall N; Nimmo G; Schooneveldt J; Kelly R; Alfredson D
    Commun Dis Intell; 1998 Nov; 22(12):265-9. PubMed ID: 9882923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.